findmyKOL
Clinical trialNCT02981368CompletedPhase 2/PHASE3Interventional

Study of 18F-DCFPyL PET/CT Imaging in Patients With Prostate Cancer

SponsorProgenics Pharmaceuticals, Inc.Enrollment385Prostate Cancer
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This study evaluates the safety and diagnostic performance of 18F-DCFPyL Injection in patients with at least high risk prostate cancer who are planned for radical prostatectomy with lymphadenectomy (Cohort A) or in patients with locally recurrent or metastatic disease willing to undergo biopsy (Cohort B). Cohort B is complete and no longer recruiting subjects.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • Jewish General Hospital

    Montreal, Quebec, Canada

  • Centre Hospitalier Universitaire de Quebec (chuq)

    Québec, Canada

United States
  • University of California at San Francisco (ucsf) - Mt. Zion Hospital

    San Francisco, California, United States

  • Yale University Department of Radiology and Biomedical Imaging

    New Haven, Connecticut, United States

  • University of Chicago

    Chicago, Illinois, United States

  • Johns Hopkins University

    Baltimore, Maryland, United States

  • Dana Farber Cancer Institute

    Boston, Massachusetts, United States

  • University of Michigan Cancer Center

    Ann Arbor, Michigan, United States

  • Washington University Mallinckrodt Institute of Radilogy

    St Louis, Missouri, United States

  • Memorial Sloan Kettering Cancer Center

    New York, New York, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Piflufolastat →
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Nov 2016
Primary completion
31 Jul 2018
Completion
31 Jul 2018
Last update posted
9 Aug 2021
Registered enrollment
385
Registry id
NCT02981368
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.